Skip to main content

LMR Partners LLP

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1578621 LONDON, X0

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$109,800
-$120,300 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 155 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Derivatives in FULC

reported options exposure · as of Jun 30, 2026
CallValue
$18,300
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. FULC ranks #57 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,300 5,000
2026-06-30 $109,800 30,000
2026-03-31 $230,100 30,000
2025-12-31 $339,300 30,000
2025-09-30 $276,000 30,000
2025-06-30 $344,000 50,000
2024-12-31 $528,750 112,500
2024-09-30 $150,297 42,100
2024-03-31 $165,568 17,539
2021-09-30 $846,300 30,000